

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | primary alcohol catabolic process (GO:0034310) | 9.51597582 |
| 2 | cellular glucuronidation (GO:0052695) | 7.17755019 |
| 3 | glucuronate metabolic process (GO:0019585) | 6.75849775 |
| 4 | uronic acid metabolic process (GO:0006063) | 6.75849775 |
| 5 | ethanol oxidation (GO:0006069) | 6.24927460 |
| 6 | retinal metabolic process (GO:0042574) | 6.10464037 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 5.94486803 |
| 8 | * glycoside metabolic process (GO:0016137) | 5.72393326 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.70942731 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.65270959 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.65270959 |
| 12 | ethanol metabolic process (GO:0006067) | 5.48733667 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.46928314 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 5.46928314 |
| 15 | exogenous drug catabolic process (GO:0042738) | 5.34411723 |
| 16 | regulation of fibrinolysis (GO:0051917) | 5.13491446 |
| 17 | primary alcohol metabolic process (GO:0034308) | 4.96645062 |
| 18 | * progesterone metabolic process (GO:0042448) | 4.95754646 |
| 19 | drug catabolic process (GO:0042737) | 4.91623110 |
| 20 | flavonoid metabolic process (GO:0009812) | 4.83733717 |
| 21 | regulation of protein activation cascade (GO:2000257) | 4.57968544 |
| 22 | urea metabolic process (GO:0019627) | 4.56353125 |
| 23 | fibrinolysis (GO:0042730) | 4.51184214 |
| 24 | * quinone metabolic process (GO:1901661) | 4.45773172 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 4.41634700 |
| 26 | cellular aldehyde metabolic process (GO:0006081) | 4.37891245 |
| 27 | bile acid metabolic process (GO:0008206) | 4.37747492 |
| 28 | protein carboxylation (GO:0018214) | 4.32255660 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.32255660 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.29901556 |
| 31 | regulation of complement activation (GO:0030449) | 4.22102728 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.15774621 |
| 33 | bile acid and bile salt transport (GO:0015721) | 4.09108730 |
| 34 | glyoxylate metabolic process (GO:0046487) | 4.07385019 |
| 35 | low-density lipoprotein particle clearance (GO:0034383) | 4.05674930 |
| 36 | regulation of plasminogen activation (GO:0010755) | 4.04215617 |
| 37 | epoxygenase P450 pathway (GO:0019373) | 3.98837346 |
| 38 | drug metabolic process (GO:0017144) | 3.96359603 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 3.93033273 |
| 40 | cysteine metabolic process (GO:0006534) | 3.91565805 |
| 41 | urea cycle (GO:0000050) | 3.90927545 |
| 42 | acylglycerol homeostasis (GO:0055090) | 3.80952155 |
| 43 | triglyceride homeostasis (GO:0070328) | 3.80952155 |
| 44 | cyclooxygenase pathway (GO:0019371) | 3.77441268 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.76223794 |
| 46 | triglyceride catabolic process (GO:0019433) | 3.75914764 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 3.64447381 |
| 48 | * C21-steroid hormone metabolic process (GO:0008207) | 3.62640608 |
| 49 | negative regulation of lipase activity (GO:0060192) | 3.60175766 |
| 50 | bile acid biosynthetic process (GO:0006699) | 3.59224718 |
| 51 | neutral lipid catabolic process (GO:0046461) | 3.59113482 |
| 52 | acylglycerol catabolic process (GO:0046464) | 3.59113482 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.57734385 |
| 54 | intestinal absorption (GO:0050892) | 3.55388654 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 3.53213198 |
| 56 | omega-hydroxylase P450 pathway (GO:0097267) | 3.52278584 |
| 57 | response to nitrosative stress (GO:0051409) | 3.50171992 |
| 58 | negative regulation of blood coagulation (GO:0030195) | 3.47605759 |
| 59 | negative regulation of hemostasis (GO:1900047) | 3.47605759 |
| 60 | retinoid metabolic process (GO:0001523) | 3.44540018 |
| 61 | blood coagulation, intrinsic pathway (GO:0007597) | 3.43812945 |
| 62 | acute-phase response (GO:0006953) | 3.42966835 |
| 63 | diterpenoid metabolic process (GO:0016101) | 3.40519878 |
| 64 | terpenoid metabolic process (GO:0006721) | 3.36890715 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.32269230 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.31438622 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 3.31438622 |
| 68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30368934 |
| 69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30368934 |
| 70 | negative regulation of coagulation (GO:0050819) | 3.28408688 |
| 71 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.28244635 |
| 72 | drug transmembrane transport (GO:0006855) | 3.25778282 |
| 73 | xenobiotic metabolic process (GO:0006805) | 3.24798914 |
| 74 | retinol metabolic process (GO:0042572) | 3.21815682 |
| 75 | negative regulation of wound healing (GO:0061045) | 3.21787279 |
| 76 | retinoic acid metabolic process (GO:0042573) | 3.21096870 |
| 77 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12871045 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 3.11786821 |
| 79 | positive regulation of blood coagulation (GO:0030194) | 3.11658906 |
| 80 | positive regulation of hemostasis (GO:1900048) | 3.11658906 |
| 81 | * secondary metabolic process (GO:0019748) | 3.09428045 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 3.08335348 |
| 83 | pentose-phosphate shunt (GO:0006098) | 3.06448771 |
| 84 | NADPH regeneration (GO:0006740) | 3.01751738 |
| 85 | cofactor catabolic process (GO:0051187) | 3.00976606 |
| 86 | coenzyme catabolic process (GO:0009109) | 2.99943284 |
| 87 | androgen biosynthetic process (GO:0006702) | 2.97681130 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 2.96206689 |
| 89 | tyrosine metabolic process (GO:0006570) | 2.95103532 |
| 90 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.94295248 |
| 91 | xenobiotic catabolic process (GO:0042178) | 2.93938997 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 2.93330132 |
| 93 | macromolecular complex remodeling (GO:0034367) | 2.93330132 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93330132 |
| 95 | fatty acid homeostasis (GO:0055089) | 2.93154409 |
| 96 | positive regulation of coagulation (GO:0050820) | 2.91954778 |
| 97 | * daunorubicin metabolic process (GO:0044597) | 12.6368709 |
| 98 | * polyketide metabolic process (GO:0030638) | 12.6368709 |
| 99 | * doxorubicin metabolic process (GO:0044598) | 12.6368709 |
| 100 | * aminoglycoside antibiotic metabolic process (GO:0030647) | 11.0240410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.55152068 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.97995078 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.96717737 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.22580655 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11291395 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.93203532 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.91618876 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.86298491 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.57354805 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05494265 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.03706364 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.00678890 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.84992912 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.74616873 |
| 15 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.59140179 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.46124456 |
| 17 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.42897068 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39507533 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.00189794 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96512553 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91539785 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.89351760 |
| 23 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.80546917 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80453498 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71923711 |
| 26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.69351569 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63529461 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61249336 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.57892166 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52715969 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52640855 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.52402621 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50798689 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50556852 |
| 35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.43861030 |
| 36 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.43861030 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38870454 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38870454 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37868327 |
| 40 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.36326204 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34540502 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32477159 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32315857 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32289282 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29523550 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26230569 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22796484 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17261893 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15861826 |
| 50 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12734371 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12443251 |
| 52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10909094 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09136745 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08182750 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03846834 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03521693 |
| 57 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02181102 |
| 58 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01963019 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00618147 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00214047 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99624595 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99220114 |
| 63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98367235 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95888923 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94849153 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93018968 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92306637 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91372995 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91104835 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90088943 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90088943 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89542195 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89482956 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89460341 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88937242 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88909905 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86371204 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85636828 |
| 79 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.84898020 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84209510 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84024316 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83225077 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81894993 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78774655 |
| 85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77996817 |
| 86 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77904161 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76966496 |
| 88 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76835359 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75894989 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75852089 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74893702 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74608028 |
| 93 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.74163869 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72418220 |
| 95 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71781819 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70666259 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.70258434 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70069186 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69077414 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68992823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.60439635 |
| 2 | MP0005365_abnormal_bile_salt | 5.26884594 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.23087429 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.29048575 |
| 5 | MP0005360_urolithiasis | 3.70366563 |
| 6 | MP0005670_abnormal_white_adipose | 3.42585774 |
| 7 | MP0003868_abnormal_feces_composition | 3.42234772 |
| 8 | MP0003252_abnormal_bile_duct | 3.01940181 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.86269011 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.81259040 |
| 11 | MP0003195_calcinosis | 2.62010164 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.34717289 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.34669077 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.25867478 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.18653448 |
| 16 | MP0003186_abnormal_redox_activity | 2.11006541 |
| 17 | MP0005332_abnormal_amino_acid | 1.96935952 |
| 18 | MP0009840_abnormal_foam_cell | 1.95765461 |
| 19 | MP0002971_abnormal_brown_adipose | 1.93671964 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.90875823 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.81249258 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.75662435 |
| 23 | MP0004130_abnormal_muscle_cell | 1.74289334 |
| 24 | MP0000609_abnormal_liver_physiology | 1.70729757 |
| 25 | MP0001661_extended_life_span | 1.69339108 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 1.68579049 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.57370905 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.46813116 |
| 29 | MP0003959_abnormal_lean_body | 1.31522421 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.31358527 |
| 31 | MP0003011_delayed_dark_adaptation | 1.29039621 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.26974309 |
| 33 | MP0004272_abnormal_basement_membrane | 1.26396048 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.24910745 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23701751 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.22138833 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.20152130 |
| 38 | MP0001764_abnormal_homeostasis | 1.19554208 |
| 39 | MP0002970_abnormal_white_adipose | 1.18864457 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.18704961 |
| 41 | MP0005164_abnormal_response_to | 1.16216703 |
| 42 | MP0005334_abnormal_fat_pad | 1.15001929 |
| 43 | MP0005408_hypopigmentation | 1.10711029 |
| 44 | MP0009115_abnormal_fat_cell | 1.06075361 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.04312084 |
| 46 | MP0009697_abnormal_copulation | 1.04219574 |
| 47 | MP0005023_abnormal_wound_healing | 1.02135743 |
| 48 | MP0005248_abnormal_Harderian_gland | 0.97973205 |
| 49 | MP0005275_abnormal_skin_tensile | 0.94430770 |
| 50 | MP0009053_abnormal_anal_canal | 0.94154359 |
| 51 | MP0005451_abnormal_body_composition | 0.91082582 |
| 52 | MP0005503_abnormal_tendon_morphology | 0.89616799 |
| 53 | MP0006138_congestive_heart_failure | 0.88721130 |
| 54 | MP0000467_abnormal_esophagus_morphology | 0.88115057 |
| 55 | MP0002909_abnormal_adrenal_gland | 0.87598839 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.85716666 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.85410816 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.84997107 |
| 59 | MP0002796_impaired_skin_barrier | 0.83936727 |
| 60 | MP0003690_abnormal_glial_cell | 0.81514958 |
| 61 | MP0000598_abnormal_liver_morphology | 0.80088540 |
| 62 | MP0005535_abnormal_body_temperature | 0.79931161 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.78421145 |
| 64 | MP0005448_abnormal_energy_balance | 0.75138199 |
| 65 | MP0000858_altered_metastatic_potential | 0.71229661 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.71007433 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 0.68986232 |
| 68 | MP0002060_abnormal_skin_morphology | 0.68576320 |
| 69 | MP0009642_abnormal_blood_homeostasis | 0.68291214 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.67856211 |
| 71 | MP0000751_myopathy | 0.67550173 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.66259491 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.65832591 |
| 74 | MP0001915_intracranial_hemorrhage | 0.65014710 |
| 75 | MP0009763_increased_sensitivity_to | 0.64528761 |
| 76 | MP0005266_abnormal_metabolism | 0.60943481 |
| 77 | MP0005452_abnormal_adipose_tissue | 0.60865367 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.60103233 |
| 79 | MP0004883_abnormal_blood_vessel | 0.58700824 |
| 80 | MP0002108_abnormal_muscle_morphology | 0.58518433 |
| 81 | MP0000249_abnormal_blood_vessel | 0.57224851 |
| 82 | MP0002132_abnormal_respiratory_system | 0.57087914 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.56585382 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 0.54905332 |
| 85 | MP0005083_abnormal_biliary_tract | 0.54866390 |
| 86 | MP0000604_amyloidosis | 0.53972494 |
| 87 | MP0003828_pulmonary_edema | 0.53299349 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.53029169 |
| 89 | MP0000566_synostosis | 0.52656023 |
| 90 | MP0005165_increased_susceptibility_to | 0.50146231 |
| 91 | MP0001881_abnormal_mammary_gland | 0.49915599 |
| 92 | MP0003953_abnormal_hormone_level | 0.49367306 |
| 93 | MP0003091_abnormal_cell_migration | 0.48729912 |
| 94 | MP0005647_abnormal_sex_gland | 0.47694007 |
| 95 | MP0008469_abnormal_protein_level | 0.46669123 |
| 96 | MP0002168_other_aberrant_phenotype | 0.46258488 |
| 97 | MP0004233_abnormal_muscle_weight | 0.46214481 |
| 98 | MP0003879_abnormal_hair_cell | 0.45818711 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.45504293 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.44933385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.35349267 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.93372760 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 6.18015218 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.16942418 |
| 5 | Complement deficiency (HP:0004431) | 5.99094373 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.87290906 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.31392852 |
| 8 | Abnormality of complement system (HP:0005339) | 5.20694083 |
| 9 | Fat malabsorption (HP:0002630) | 4.60432827 |
| 10 | Steatorrhea (HP:0002570) | 4.56381103 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.25414048 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17429427 |
| 13 | Xanthomatosis (HP:0000991) | 3.98274891 |
| 14 | Vascular calcification (HP:0004934) | 3.92066999 |
| 15 | Glomerulonephritis (HP:0000099) | 3.89353300 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.82001446 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.79792778 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.70857310 |
| 19 | Joint hemorrhage (HP:0005261) | 3.67768038 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66304822 |
| 21 | Cardiovascular calcification (HP:0011915) | 3.62074874 |
| 22 | Mitral stenosis (HP:0001718) | 3.56240255 |
| 23 | Rickets (HP:0002748) | 3.51325745 |
| 24 | Hemorrhage of the eye (HP:0011885) | 3.47011917 |
| 25 | Back pain (HP:0003418) | 3.43046147 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.40511782 |
| 27 | Spontaneous abortion (HP:0005268) | 3.35261791 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.29973787 |
| 29 | Nephritis (HP:0000123) | 3.28752965 |
| 30 | Vertebral compression fractures (HP:0002953) | 3.15272485 |
| 31 | Hydroxyprolinuria (HP:0003080) | 2.88667474 |
| 32 | Abnormality of proline metabolism (HP:0010907) | 2.88667474 |
| 33 | Acanthosis nigricans (HP:0000956) | 2.88266858 |
| 34 | Abnormality of the Achilles tendon (HP:0005109) | 2.88039820 |
| 35 | Hypertriglyceridemia (HP:0002155) | 2.78404565 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76916712 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.75802938 |
| 38 | Hyperammonemia (HP:0001987) | 2.71788243 |
| 39 | Epidermoid cyst (HP:0200040) | 2.69358439 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.65697328 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.50172851 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.45696785 |
| 43 | Myocardial infarction (HP:0001658) | 2.43816060 |
| 44 | Tetraparesis (HP:0002273) | 2.40680967 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.37994918 |
| 46 | Skin nodule (HP:0200036) | 2.36367185 |
| 47 | Oligomenorrhea (HP:0000876) | 2.34303544 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.31875054 |
| 49 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.22139065 |
| 50 | Abnormality of vitamin metabolism (HP:0100508) | 2.13165327 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.12034841 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.11331606 |
| 53 | Arthropathy (HP:0003040) | 2.10001245 |
| 54 | Rhinitis (HP:0012384) | 2.07721083 |
| 55 | Amyloidosis (HP:0011034) | 2.07442802 |
| 56 | Bifid scrotum (HP:0000048) | 2.06777984 |
| 57 | Abnormality of carpal bone ossification (HP:0006257) | 1.95843300 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 1.94916677 |
| 59 | Osteomalacia (HP:0002749) | 1.93645401 |
| 60 | Gingival bleeding (HP:0000225) | 1.91170756 |
| 61 | Glomerulosclerosis (HP:0000096) | 1.90642469 |
| 62 | Increased serum ferritin (HP:0003281) | 1.89915616 |
| 63 | Abnormal delivery (HP:0001787) | 1.88420881 |
| 64 | Focal segmental glomerulosclerosis (HP:0000097) | 1.88012246 |
| 65 | Short nail (HP:0001799) | 1.86283731 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 1.85956832 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84614738 |
| 68 | Abnormal cartilage morphology (HP:0002763) | 1.84365021 |
| 69 | Vascular tortuosity (HP:0004948) | 1.78261744 |
| 70 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.78219657 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.78219657 |
| 72 | Insulin resistance (HP:0000855) | 1.77892781 |
| 73 | Achilles tendon contracture (HP:0001771) | 1.76409589 |
| 74 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.76277553 |
| 75 | Hypophosphatemic rickets (HP:0004912) | 1.75937290 |
| 76 | Arterial tortuosity (HP:0005116) | 1.74018899 |
| 77 | Polycythemia (HP:0001901) | 1.72296493 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 1.72233629 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 1.69607151 |
| 80 | Mucopolysacchariduria (HP:0008155) | 1.65400757 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65400757 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 1.65060593 |
| 83 | Hyperglycinemia (HP:0002154) | 1.64471496 |
| 84 | Paraparesis (HP:0002385) | 1.61758091 |
| 85 | Purpura (HP:0000979) | 1.61432474 |
| 86 | Abnormal ciliary motility (HP:0012262) | 1.59926559 |
| 87 | Increased connective tissue (HP:0009025) | 1.58596229 |
| 88 | Hypoglycemic coma (HP:0001325) | 1.58470545 |
| 89 | Neonatal onset (HP:0003623) | 1.58028004 |
| 90 | Nausea (HP:0002018) | 1.57989939 |
| 91 | Cerebral palsy (HP:0100021) | 1.57917087 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.57462118 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 1.57462118 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 1.56536462 |
| 95 | Glycosuria (HP:0003076) | 1.56536462 |
| 96 | Proximal tubulopathy (HP:0000114) | 1.54792988 |
| 97 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.54422665 |
| 98 | Elevated alkaline phosphatase (HP:0003155) | 1.54015506 |
| 99 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.52619313 |
| 100 | Absent/shortened dynein arms (HP:0200106) | 1.52619313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.55053898 |
| 2 | MST1R | 4.34166988 |
| 3 | TESK1 | 3.36596103 |
| 4 | IRAK3 | 3.25559692 |
| 5 | ERBB4 | 2.95063624 |
| 6 | EPHA2 | 2.69880476 |
| 7 | TRIB3 | 2.66980751 |
| 8 | LATS2 | 2.37231122 |
| 9 | RIPK1 | 2.27850486 |
| 10 | MET | 2.25373256 |
| 11 | SIK1 | 2.20547647 |
| 12 | MAPKAPK3 | 2.10743496 |
| 13 | DDR2 | 2.06290153 |
| 14 | FGFR4 | 2.04722581 |
| 15 | ARAF | 2.02778222 |
| 16 | PDGFRA | 1.78940892 |
| 17 | MAP3K12 | 1.77864908 |
| 18 | ABL2 | 1.67441472 |
| 19 | EPHA3 | 1.57867700 |
| 20 | EPHB2 | 1.55315228 |
| 21 | LIMK1 | 1.53248337 |
| 22 | MYLK | 1.51998311 |
| 23 | PRKAA2 | 1.50590436 |
| 24 | EIF2AK1 | 1.48733844 |
| 25 | MAP3K3 | 1.45883744 |
| 26 | MAP3K2 | 1.42828559 |
| 27 | SCYL2 | 1.39212944 |
| 28 | TBK1 | 1.38979232 |
| 29 | MAPK15 | 1.36084774 |
| 30 | LATS1 | 1.31389418 |
| 31 | ICK | 1.31272882 |
| 32 | PBK | 1.15872950 |
| 33 | LMTK2 | 1.15122064 |
| 34 | TGFBR2 | 1.13797428 |
| 35 | STK38 | 1.03871192 |
| 36 | MAP3K9 | 1.02179184 |
| 37 | TRPM7 | 1.00627082 |
| 38 | PAK4 | 0.99807117 |
| 39 | PTK2 | 0.99064979 |
| 40 | TTN | 0.98939686 |
| 41 | NEK9 | 0.95521746 |
| 42 | EPHB1 | 0.94077951 |
| 43 | MAPK11 | 0.93656701 |
| 44 | NME2 | 0.86709933 |
| 45 | RPS6KB2 | 0.86369144 |
| 46 | PDK2 | 0.82082594 |
| 47 | CAMK2G | 0.81958479 |
| 48 | PDPK1 | 0.81567775 |
| 49 | FER | 0.74613634 |
| 50 | CDK8 | 0.72826858 |
| 51 | MAP2K4 | 0.72677112 |
| 52 | CDK9 | 0.70993484 |
| 53 | PIK3CG | 0.69686743 |
| 54 | PRKACG | 0.69168931 |
| 55 | FGFR3 | 0.69113982 |
| 56 | ILK | 0.68686236 |
| 57 | PIM2 | 0.68212040 |
| 58 | MAP2K1 | 0.68052947 |
| 59 | PRKAA1 | 0.66927629 |
| 60 | PRPF4B | 0.64573348 |
| 61 | MAP3K1 | 0.61710504 |
| 62 | STK38L | 0.60330335 |
| 63 | NTRK1 | 0.59952814 |
| 64 | CDC42BPA | 0.58774525 |
| 65 | IGF1R | 0.57155697 |
| 66 | MAP3K6 | 0.56326193 |
| 67 | MAP3K13 | 0.54507745 |
| 68 | PIK3CA | 0.51836801 |
| 69 | MAPKAPK5 | 0.50849838 |
| 70 | CAMK1D | 0.50759753 |
| 71 | MTOR | 0.49175819 |
| 72 | CAMK2B | 0.48901504 |
| 73 | PRKG2 | 0.48795967 |
| 74 | PHKG2 | 0.48687671 |
| 75 | PHKG1 | 0.48687671 |
| 76 | GSK3A | 0.48646236 |
| 77 | PINK1 | 0.48203219 |
| 78 | AKT2 | 0.46726752 |
| 79 | PDGFRB | 0.46371006 |
| 80 | MAPK4 | 0.44659326 |
| 81 | PRKCE | 0.43984786 |
| 82 | EEF2K | 0.43757577 |
| 83 | CAMKK2 | 0.42597723 |
| 84 | KSR2 | 0.41280105 |
| 85 | TYK2 | 0.37817308 |
| 86 | ERBB3 | 0.37283019 |
| 87 | MAP3K7 | 0.36048887 |
| 88 | CDK6 | 0.35519070 |
| 89 | MAPK12 | 0.32939823 |
| 90 | LRRK2 | 0.32479305 |
| 91 | NEK1 | 0.31405373 |
| 92 | PAK2 | 0.30944380 |
| 93 | MELK | 0.30729611 |
| 94 | DAPK3 | 0.30711315 |
| 95 | CAMK1 | 0.30672443 |
| 96 | BMX | 0.30008265 |
| 97 | SRC | 0.29933149 |
| 98 | GRK5 | 0.28792165 |
| 99 | PRKCD | 0.27876291 |
| 100 | IRAK1 | 0.27710493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.35938743 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.85631830 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.49365619 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.31695659 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.20252596 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.17244727 |
| 7 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.02824163 |
| 8 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.00483555 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.76783679 |
| 10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.66116825 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.65286447 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59683547 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.57758756 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.43161999 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33652209 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.29676668 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14537973 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.12866676 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.02894695 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92809119 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84633554 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79257270 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62070965 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58595763 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54409140 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53415253 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.52937613 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49385530 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.38129866 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35066548 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.33412634 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31434873 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26395721 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23320595 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18526420 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15664455 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12815271 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07328424 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.05334850 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04789162 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04563936 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02858636 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99468738 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99393435 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95853874 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95066338 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92203581 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92179668 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89816151 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87534694 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86530704 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81776863 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.79712400 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77582883 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73144700 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69556112 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67116295 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59271710 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52902233 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47155298 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46736803 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44935704 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44421850 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43971377 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43907678 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39893675 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.38088000 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37084684 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.36511141 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35386485 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33076645 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31852917 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31534084 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30987975 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28269460 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28199913 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27614981 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25832417 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23918665 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22887766 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19689109 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19598438 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.18333000 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17861204 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17698152 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15007998 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12543030 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07752084 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.05800034 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03899413 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02458283 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01088647 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0768597 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0716432 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0686201 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | -0.0663455 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0403304 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0330597 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0035344 |
| 100 | Pertussis_Homo sapiens_hsa05133 | -0.0031302 |

